Pzena Mid Cap Value Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Pzena Mid Cap Value Fund Investor Class PZVMX
- NAV / 1-Day Return $13.91 / −0.78 %
- Fund Size $73.8M
- Adjusted Expense Ratio 1.250%
- Net Expense Ratio 1.240%
- Fee Level: Distribution High
- Share Class Type No Load
- Morningstar Category Mid-Cap Value
- Equity Style Box (Funds) Small Value
- Minimum Initial Investment $5,000
- Investment Status Open
- TTM Yield 0.02%
- Turnover Ratio 31%
Morningstar’s Analysis PZVMX
Will PZVMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 37.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Baxter International Inc | 5.48 | 4M | Healthcare |
Humana Inc | 5.27 | 4M | Healthcare |
Advance Auto Parts Inc | 3.74 | 3M | Consumer Cyclical |
Robert Half Inc | 3.58 | 3M | Industrials |
Fresenius Medical Care AG ADR | 3.56 | 3M | Healthcare |
Universal Health Services Inc Class B | 3.53 | 2M | Healthcare |
Olin Corp | 3.16 | 2M | Basic Materials |
Magna International Inc | 3.11 | 2M | Consumer Cyclical |
Corebridge Financial Inc | 3.04 | 2M | Financial Services |
Globe Life Inc | 3.04 | 2M | Financial Services |